World's 1st trial of drug developed from iPS cells to begin


The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.


©2020 GPlusMedia Inc.

Login to comment

Good news! I hope it works out. Thank you Dr. Yamanaka and all other hard working researchers.

3 ( +3 / -0 )

why start with rare diseases? fop hardly seems like a disease that warrants such important research.

-4 ( +0 / -4 )

@nakanoguy04 Not to the people who have it.

3 ( +3 / -0 )

Actually rare diseases are a good start. Typically they have no therapies at all available or very ineffective treatments (think of the baby who just passed in the UK with a very rare condition). Big pharma is already hard at work on mass market disease therapies.

0 ( +0 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites